Stocks slid Friday as Wall Street’s mood darkened on the heels of soft economic data.The Dow Jones Industrial Average recorded its worst day of the year, closing down 1.7%, while the S&P 500 and ...
The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.
With 2025 underway, the AFS Health Care team highlights some of the most pressing legal issues facing the health care industry this year.
The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...
"People on the federal staff who oversee and are working to raise awareness of 988 nationally are the people who are gone," the employee, Stacey Palosky, posted on LinkedIn. Offic ...
President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive ...
The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...
CBD products made from hemp are federally legal following the Agriculture Improvement Act, which Congress passed and signed into law in 2018. But CBD oil doesn’t have Food and Drug Administration (FDA ...
President Donald Trump late Wednesday directed the Centers for Medicare and Medicaid Services (CMS) to disband a committee to ...